We are live on ! Find out more
FFTY icon

CapForce IBD 50 ETF

38 hedge funds and large institutions have $24M invested in CapForce IBD 50 ETF in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

989% more call options, than puts

Call options by funds: $806K | Put options by funds: $74K

25% more capital invested

Capital invested by funds: $19.2M → $24M (+$4.83M)

0% more funds holding

Funds holding: 3838 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

0.74% less ownership

Funds ownership: 30.28%29.53% (-0.74%)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
38
Holders Change
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
7
Increased
7
Reduced
12
Closed
7
Calls
$806K
Puts
$74K
Net Calls
+$732K
Net Calls Change
+$481K
Name Holding Trade Value Shares
Change
Change in
Stake
IPW
1
IronBridge Private Wealth
Texas
$9.7M -$56.9K -1,991 -0.7%
SAM
2
Synergy Asset Management
Washington
$1.96M +$1.72M +60,195 New
Two Sigma Investments
3
Two Sigma Investments
New York
$1.62M +$1.43M +50,000 New
IWM
4
IHT Wealth Management
Illinois
$1.56M -$199K -6,974 -13%
CPIG
5
Chicago Partners Investment Group
Illinois
$1.28M -$165K -5,782 -13%
Citadel Advisors
6
Citadel Advisors
Florida
$1.06M +$554K +19,403 +145%
CFP
7
Comprehensive Financial Planning
Pennsylvania
$996K +$876K +30,666 New
AWS
8
Atria Wealth Solutions
New York
$976K +$858K +30,036 New
Wealth Enhancement Advisory Services
9
Wealth Enhancement Advisory Services
Minnesota
$927K +$35.4K +1,238 +5%
DSCM
10
Del-Sette Capital Management
New York
$667K +$227K +7,954 +63%
Cambridge Investment Research Advisors
11
Cambridge Investment Research Advisors
Iowa
$444K -$7.31K -256 -2%
LPL Financial
12
LPL Financial
California
$427K -$448K -15,673 -54%
NA
13
NewEdge Advisors
Louisiana
$412K +$38.2K +1,338 +12%
Bank of America
14
Bank of America
North Carolina
$404K +$268K +9,391 +307%
QC
15
Quadrature Capital
United Kingdom
$376K -$16.9K -591 -5%
Osaic Holdings
16
Osaic Holdings
Arizona
$355K -$21.3K -746 -6%
BIG
17
Brookwood Investment Group
Arizona
$300K +$264K +9,232 New
Raymond James Financial
18
Raymond James Financial
Florida
$162K -$144K -5,057 -50%
Simplex Trading
19
Simplex Trading
Illinois
$92K +$32.5K +1,138 +66%
BlackRock
20
BlackRock
New York
$73.4K +$59.4K +2,081 +1,163%
FFA
21
Farther Finance Advisors
California
$56.8K +$49.9K +1,747 New
ME
22
McIlrath & Eck
Washington
$27.6K
UBS Group
23
UBS Group
Switzerland
$24.3K
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$18K -$284K -9,957 -95%
FP
25
Financial Perspectives
Minnesota
$18K

FFTY Hedge Fund Activity: Q2 2025 in Review

38 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q2 2025, worth a combined $24M — up 25% from $19.2M a quarter earlier.

Fund positioning in FFTY was balanced in Q2 2025: 7 funds opened new positions, 7 closed out, 7 added to existing stakes and 12 trimmed.

The largest buyer was Synergy Asset Management, opening a new position worth an estimated $1.72M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.64M sold.

  • 38 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $24M of CapForce IBD 50 ETF stock for Q2 2025, up 25% quarter-over-quarter.
  • 7 funds opened new CapForce IBD 50 ETF positions in Q2 2025 and 7 closed out, a net change of 0 holders.
  • The largest CapForce IBD 50 ETF buyer in Q2 2025 was Synergy Asset Management, an estimated $1.72M added.
  • The largest CapForce IBD 50 ETF seller in Q2 2025 was Susquehanna International Group, an estimated $1.64M sold.

Based on aggregated 13F filings for Q2 2025.